These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26975738)

  • 1. Evaluating the Impact of Total Intravenous Anesthesia on the Clinical Outcomes and Perioperative NLR and PLR Profiles of Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
    Owusu-Agyemang P; Cata JP; Fournier KF; Zavala AM; Soliz J; Hernandez M; Hayes-Jordan A; Gottumukkala V
    Ann Surg Oncol; 2016 Aug; 23(8):2419-29. PubMed ID: 26975738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing Postoperative Complications and Inflammatory Markers Using Total Intravenous Anesthesia Versus Volatile Gas Anesthesia for Pancreatic Cancer Surgery.
    Soliz JM; Ifeanyi IC; Katz MH; Wilks J; Cata JP; McHugh T; Fleming JB; Feng L; Rahlfs T; Bruno M; Gottumukkala V
    Anesth Pain Med; 2017 Aug; 7(4):e13879. PubMed ID: 29344445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Nutrition Status and Postoperative Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Reece L; Dragicevich H; Lewis C; Rothwell C; Fisher OM; Carey S; Alzahrani NA; Liauw W; Morris DL
    Ann Surg Oncol; 2019 Aug; 26(8):2622-2630. PubMed ID: 31123932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaesthetic management of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei: a retrospective audit.
    Shiralkar SP; Kerr P; Scott J; Sivalingam P
    Anaesth Intensive Care; 2017 Jul; 45(4):490-498. PubMed ID: 28673220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative platelet-lymphocyte ratio is an independent prognostic marker and superior to carcinoembryonic antigen in colorectal peritoneal carcinomatosis patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Bong TSH; Tan GHC; Chia C; Soo KC; Teo MCC
    Int J Clin Oncol; 2017 Jun; 22(3):511-518. PubMed ID: 28138878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anesthesia and pain management of pediatric cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Suchar AM; Lane J; King AC; Hayes AA; Phelps JR
    Paediatr Anaesth; 2023 Mar; 33(3):193-200. PubMed ID: 36052662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total intravenous anesthesia decreases hospital stay but not incidence of postoperative pulmonary complications after lung resection surgery: a propensity score matching study.
    Hsu FK; Cheng HW; Teng WN; Hsu PK; Hsu HS; Chang WK; Ting CK
    BMC Anesthesiol; 2023 Oct; 23(1):345. PubMed ID: 37848832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
    Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
    Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Systemic Inflammatory Indices, NLR, PLR, and MPV, for Predicting 1-Year Survival of Patients Undergoing Cytoreductive Surgery with HIPEC.
    Kim NY; Chun DH; Kim SY; Kim NK; Baik SH; Hong JH; Kim KS; Shin CS
    J Clin Med; 2019 Apr; 8(5):. PubMed ID: 31035703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
    Baumgartner JM; Kwong TG; Ma GL; Messer K; Kelly KJ; Lowy AM
    Ann Surg Oncol; 2016 May; 23(5):1609-17. PubMed ID: 26678406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a retrospective cohort analysis.
    Hurdle H; Bishop G; Walker A; Moazeni A; Paloucci EO; Temple W; Mack L; Shing M
    Can J Anaesth; 2017 Nov; 64(11):1144-1152. PubMed ID: 28853010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pre-operative neutrophil-lymphocyte ratio predicts overall and disease-free survival following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with pseudomxyoma peritonei of appendiceal origin.
    Rangarajan K; Chandrakumaran K; Dayal S; Mohamed F; Moran BJ; Cecil TD
    Int J Hyperthermia; 2018 Aug; 34(5):559-563. PubMed ID: 29063804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Outcomes After Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy.
    Gani F; Conca-Cheng AM; Nettles B; Ahuja N; Johnston FM
    J Surg Res; 2019 Feb; 234():240-248. PubMed ID: 30527480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anesthesia and Pain Management for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Desmoplastic Small Round Cell Tumors in Children, Adolescents, and Young Adults.
    Anghelescu DL; Brown CL; Murphy AJ; Davidoff AM; Dickson PV; Glazer ES; Stiles ZE; Bishop MW; Douthitt L; Deneve JL
    Ann Surg Oncol; 2019 Jan; 26(1):131-138. PubMed ID: 30353396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison between inhalational (Desflurane) and total intravenous anaesthesia (Propofol and dexmedetomidine) in improving postoperative recovery for morbidly obese patients undergoing laparoscopic sleeve gastrectomy: A double-blinded randomised controlled trial.
    Elbakry AE; Sultan WE; Ibrahim E
    J Clin Anesth; 2018 Mar; 45():6-11. PubMed ID: 29223575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis.
    Wu X; Li Z; Li Z; Jia Y; Shan F; Ji X; Bu Z; Zhang L; Wu A; Ji J
    J Surg Oncol; 2015 Jun; 111(7):840-7. PubMed ID: 25864884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures.
    Foster JM; Sleightholm R; Patel A; Shostrom V; Hall B; Neilsen B; Bartlett D; Smith L
    JAMA Netw Open; 2019 Jan; 2(1):e186847. PubMed ID: 30646202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intraoperative dexmedetomidine on renal function after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a randomized, placebo-controlled trial.
    Song Y; Kim DH; Kwon TD; Han DW; Baik SH; Jung HH; Kim JY
    Int J Hyperthermia; 2019; 36(1):1-8. PubMed ID: 30354794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does early post-operative intraperitoneal chemotherapy (EPIC) for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) make a difference?
    Tan GH; Ong WS; Chia CS; Tham CK; Soo KC; Teo MC
    Int J Hyperthermia; 2016 May; 32(3):281-8. PubMed ID: 26862667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion is Feasible and Offers Survival Benefit in Select Patients with Peritoneal Metastases.
    Choudry HA; Bednar F; Shuai Y; Jones HL; Pai RK; Pingpank JF; Ahrendt SS; Holtzman MP; Zeh HJ; Bartlett DL
    Ann Surg Oncol; 2019 May; 26(5):1445-1453. PubMed ID: 30825033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.